Karuna Therapeutics

/Karuna Therapeutics

IPO

Karuna Therapeutics

Biopharmaceutical

We are an innovative clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical need.

Symbol

KRTX

Price Range
$15.00 - $17.00

Final Shares
4,375,000

Anticipated Date
June 28, 2019

Underwriters
GOLDMAN SACHS & CO. LLC ,CITIGROUP GLOBAL MARKETS INC.,WELLS FARGO SECURITIES, LLC

This offering is no longer available

To view the prospectus for Karuna Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277